Related Experiment Videos
Kimura's disease in children: a 9 years prospective study
1ENT Department, Victoria Hospital, Bangalore Medical College, Bangalore, India. drbviswanatha@yahoo.co.in
International Journal of Pediatric Otorhinolaryngology
|June 26, 2007
Summary
Kimura's disease, a rare inflammatory condition, most commonly affects the head and neck in children. Surgical treatment offers the lowest recurrence rates compared to steroid therapy.
Area of Science:
- Dermatology
- Pediatric Medicine
- Head and Neck Surgery
Background:
- Kimura's disease is a rare, chronic inflammatory disorder affecting subcutaneous tissues, primarily in the head and neck.
- Lesions can mimic neoplasms, necessitating awareness among head and neck surgeons.
- Association with lymphadenopathy and salivary gland enlargement is common.
Purpose of the Study:
- To investigate the clinical presentations, management strategies, and complications of Kimura's disease in pediatric patients.
- To evaluate treatment outcomes and recurrence rates in children diagnosed with Kimura's disease.
Main Methods:
- A prospective study conducted over 9 years (1998-2006) included 18 histopathologically confirmed cases of Kimura's disease.
- Diagnostic procedures included blood eosinophil count, serum IgE estimation, fine needle aspiration cytology, and excision biopsy.
- Treatment modalities included surgery (excision biopsy) and corticosteroid therapy.
Main Results:
- Painless head and neck swelling was the primary presentation, with the post-auricular region being the most common site (50%).
- Elevated blood eosinophil counts (88.8%) and serum IgE levels (83.3%) were frequently observed.
- Surgical treatment resulted in a significantly lower recurrence rate (6.6%) compared to steroid therapy (66.6%).
Conclusions:
- Kimura's disease commonly involves the post-auricular region and affects individuals in their second decade of life.
- Surgery is the preferred treatment modality due to a lower recurrence rate compared to steroids.
- Nephrotic syndrome is the identified systemic complication.